Inherited cardiomyopathies

The advent of molecular genetics - fuelled by the progress in DNA sequencing technologies and publication of the landmark Human Genome Project over a decade ago - has had a major impact on our understanding of the architecture of disease, opening up the prospect of personalized medicine based upon k...

Full description

Bibliographic Details
Main Authors: Harper, A, Yavari, A, Ashrafian, H
Format: Journal article
Language:English
Published: Elsevier 2014
_version_ 1797062176982171648
author Harper, A
Yavari, A
Ashrafian, H
author_facet Harper, A
Yavari, A
Ashrafian, H
author_sort Harper, A
collection OXFORD
description The advent of molecular genetics - fuelled by the progress in DNA sequencing technologies and publication of the landmark Human Genome Project over a decade ago - has had a major impact on our understanding of the architecture of disease, opening up the prospect of personalized medicine based upon knowledge of an individual's genetic variants. Current management of patients with inherited cardiomyopathies is starting to integrate knowledge of an individual's genomic profile together with advancements in cardiovascular imaging. This has enhanced surveillance potential for high-risk individuals and has begun to facilitate diagnosis and, to a lesser extent, appropriate risk stratification and prognostication. This review introduces the reader to the inherited cardiomyopathies (hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy and dilated cardiomyopathy) - representing the first cardiac disorders to be accurately delineated at a molecular genetic level - and provides an insight into their molecular genetic and clinical complexity.
first_indexed 2024-03-06T20:41:50Z
format Journal article
id oxford-uuid:348d1a71-5e5e-4db6-96ef-97a1667049b5
institution University of Oxford
language English
last_indexed 2024-03-06T20:41:50Z
publishDate 2014
publisher Elsevier
record_format dspace
spelling oxford-uuid:348d1a71-5e5e-4db6-96ef-97a1667049b52022-03-26T13:26:40ZInherited cardiomyopathiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:348d1a71-5e5e-4db6-96ef-97a1667049b5EnglishSymplectic Elements at OxfordElsevier2014Harper, AYavari, AAshrafian, HThe advent of molecular genetics - fuelled by the progress in DNA sequencing technologies and publication of the landmark Human Genome Project over a decade ago - has had a major impact on our understanding of the architecture of disease, opening up the prospect of personalized medicine based upon knowledge of an individual's genetic variants. Current management of patients with inherited cardiomyopathies is starting to integrate knowledge of an individual's genomic profile together with advancements in cardiovascular imaging. This has enhanced surveillance potential for high-risk individuals and has begun to facilitate diagnosis and, to a lesser extent, appropriate risk stratification and prognostication. This review introduces the reader to the inherited cardiomyopathies (hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy and dilated cardiomyopathy) - representing the first cardiac disorders to be accurately delineated at a molecular genetic level - and provides an insight into their molecular genetic and clinical complexity.
spellingShingle Harper, A
Yavari, A
Ashrafian, H
Inherited cardiomyopathies
title Inherited cardiomyopathies
title_full Inherited cardiomyopathies
title_fullStr Inherited cardiomyopathies
title_full_unstemmed Inherited cardiomyopathies
title_short Inherited cardiomyopathies
title_sort inherited cardiomyopathies
work_keys_str_mv AT harpera inheritedcardiomyopathies
AT yavaria inheritedcardiomyopathies
AT ashrafianh inheritedcardiomyopathies